Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Celecoxib, a cyclooxygenase-2 inhibitor, improved upper gastrointestinal lesions in rheumatoid arthritis patients as assessed by endoscopic evaluation.

Tsuji S, Miyoshi H, Tomita T, Nakase T, Hamada M, Oomae T, Tsumoto C, Hirata Y, Iguchi M, Edogawa S, Kawai H, Yoshikawa H.

Mod Rheumatol. 2012 Jun;22(3):353-62. doi: 10.1007/s10165-011-0524-6. Epub 2011 Sep 9.

PMID:
21904784
2.

Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial.

Simon LS, Weaver AL, Graham DY, Kivitz AJ, Lipsky PE, Hubbard RC, Isakson PC, Verburg KM, Yu SS, Zhao WW, Geis GS.

JAMA. 1999 Nov 24;282(20):1921-8.

PMID:
10580457
3.

Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study.

Silverstein FE, Faich G, Goldstein JL, Simon LS, Pincus T, Whelton A, Makuch R, Eisen G, Agrawal NM, Stenson WF, Burr AM, Zhao WW, Kent JD, Lefkowith JB, Verburg KM, Geis GS.

JAMA. 2000 Sep 13;284(10):1247-55.

PMID:
10979111
4.

Cost-utility of celecoxib use in different treatment strategies for osteoarthritis and rheumatoid arthritis from the Quebec healthcare system perspective.

Bessette L, Risebrough N, Mittmann N, Roussy JP, Ho J, Zlateva G.

J Med Econ. 2009 Sep;12(3):246-58. doi: 10.3111/13696990903288970.

PMID:
19743942
5.

Celecoxib, a selective cyclooxygenase-2 inhibitor, reduces level of a bone resorption marker in postmenopausal women with rheumatoid arthritis.

Tsuji S, Tomita T, Nakase T, Hamada M, Kawai H, Yoshikawa H.

Int J Rheum Dis. 2014 Jan;17(1):44-9. doi: 10.1111/1756-185X.12076. Epub 2013 May 23.

PMID:
24472266
6.

Amelioration of small bowel injury by switching from nonselective nonsteroidal anti-inflammatory drugs to celecoxib in rheumatoid arthritis patients: a pilot study.

Inoue T, Iijima H, Arimitsu J, Hagihara K, Kawai S, Shiraishi E, Hiyama S, Mukai A, Shinzaki S, Nishida T, Ogata A, Tsujii M, Takehara T.

Digestion. 2014;89(2):124-32. doi: 10.1159/000357229. Epub 2014 Feb 7.

PMID:
24526219
7.
8.

Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison.

Emery P, Zeidler H, Kvien TK, Guslandi M, Naudin R, Stead H, Verburg KM, Isakson PC, Hubbard RC, Geis GS.

Lancet. 1999 Dec 18-25;354(9196):2106-11.

PMID:
10609815
9.

GI-REASONS: a novel 6-month, prospective, randomized, open-label, blinded endpoint (PROBE) trial.

Cryer B, Li C, Simon LS, Singh G, Stillman MJ, Berger MF.

Am J Gastroenterol. 2013 Mar;108(3):392-400. doi: 10.1038/ajg.2012.467. Epub 2013 Feb 12.

10.

Comparison of gastroduodenal ulcer incidence in healthy Japanese subjects taking celecoxib or loxoprofen evaluated by endoscopy: a placebo-controlled, double-blind 2-week study.

Sakamoto C, Kawai T, Nakamura S, Sugioka T, Tabira J.

Aliment Pharmacol Ther. 2013 Feb;37(3):346-54. doi: 10.1111/apt.12174. Epub 2012 Dec 10.

11.

The effects of some nonsteroidal anti-inflammatory drugs on experimental induced gastric ulcers in rats.

Batu OS, Erol K.

Inflammopharmacology. 2007 Dec;15(6):260-5. doi: 10.1007/s10787-007-1605-1.

PMID:
18236017
12.

An endoscopic study of gastroduodenal lesions induced by nonsteroidal anti-inflammatory drugs.

Cheatum DE, Arvanitakis C, Gumpel M, Stead H, Geis GS.

Clin Ther. 1999 Jun;21(6):992-1003.

PMID:
10440623
13.

Celecoxib, a selective cyclooxygenase-2 inhibitor for the treatment of rheumatoid arthritis and osteoarthritis.

Goldenberg MM.

Clin Ther. 1999 Sep;21(9):1497-513; discussion 1427-8. Review.

PMID:
10509845
15.
16.

The efficacy of rebamipide add-on therapy in arthritic patients with COX-2 selective inhibitor-related gastrointestinal events: a prospective, randomized, open-label blinded-endpoint pilot study by the GLORIA study group.

Hasegawa M, Horiki N, Tanaka K, Wakabayashi H, Tano S, Katsurahara M, Uchida A, Takei Y, Sudo A.

Mod Rheumatol. 2013 Nov;23(6):1172-8. doi: 10.1007/s10165-012-0819-2. Epub 2013 Jan 10.

PMID:
23306427
17.

Celecoxib: a review of its use for symptomatic relief in the treatment of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis.

McCormack PL.

Drugs. 2011 Dec 24;71(18):2457-89. doi: 10.2165/11208240-000000000-00000. Review.

PMID:
22141388
18.

Gastrointestinal tolerability of NSAIDs in elderly patients: a pooled analysis of 21 randomized clinical trials with celecoxib and nonselective NSAIDs.

Mallen SR, Essex MN, Zhang R.

Curr Med Res Opin. 2011 Jul;27(7):1359-66. doi: 10.1185/03007995.2011.581274. Epub 2011 May 12. Review.

PMID:
21561397
19.
20.

Pooled analysis of GI tolerability of 21 randomized controlled trials of celecoxib and nonselective NSAIDs.

Niculescu L, Li C, Huang J, Mallen S.

Curr Med Res Opin. 2009 Mar;25(3):729-40. doi: 10.1185/03007990802714382 .

PMID:
19210159

Supplemental Content

Support Center